Cerebral thrombosis
Cerebral thrombosis (CT) is the most common type of cerebral infarction. It is caused by atherosclerosis of the main trunk or cortical branches of the cerebral arteries, which leads to vascular thickening, lumen stenosis and occlusion, and thrombosis, resulting in reduced blood flow or interruption of blood supply to the local brain, ischemia and hypoxia of brain tissue, leading to softening and necrosis, and the appearance of focal neurological symptoms and signs. Therefore, it is also called "atherosclerotic cerebral thrombosis" or "thrombotic cerebral infarction" in clinical practice.
-
Site of disease:
Brain -
Infectious :
Not contagious -
Frequent population:
The incidence rate in middle-aged and elderly men is higher than that in women -
Related symptoms:
Weakness Difficulty swallowing Hypersensitivity Sensory impairment Slow response -
Concurrent disease:
Related Drugs
Flunarizine Hydrochloride Tablets
Indication: (1) Insufficient blood supply to the brain, vertebral artery ischemia, cerebral thrombosis, etc. (2) Tinnitus, dizziness. (3) Prevention of migraine. (4) Auxiliary treatment of epilepsy.
Manufacturer:
Renhetang Pharmaceutical Co., Ltd.
Ligustrazine Phosphate Tablets
Indication: Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by insufficient blood supply to the brain, cerebral thrombosis, and cerebral embolism.
Manufacturer:
Hebei Julong Pharmaceutical Co., Ltd.
Ligustrazine Phosphate Tablets
Indication: Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by insufficient blood supply to the brain, cerebral thrombosis, and cerebral embolism.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Ligustrazine Phosphate Tablets
Indication: Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by insufficient blood supply to the brain, cerebral thrombosis, and cerebral embolism.
Manufacturer:
GuangDongBangMinPharmaceutical Co., Ltd.
Ligustrazine hydrochloride
Indication: Ligustrazine hydrochloride injection is used for occlusive cerebrovascular diseases such as cerebral insufficiency, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease vasculitis.
Manufacturer:
Xi'an Li Bang Pharmaceutical Co., Ltd.
Troxerutin for injection
Indication: It is used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), thrombophlebitis, central retinitis, edema caused by increased vascular permeability, etc.
Manufacturer:
Hainan General Alliance Pharmaceutical Co., Ltd.
Troxerutin for injection
Indication: It is used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), thrombophlebitis, central retinitis, edema caused by increased vascular permeability, etc.
Troxerutin for injection
Indication: It is used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), thrombophlebitis, central retinitis, edema caused by increased vascular permeability, etc.
Manufacturer:
Nanyang Pukang Pharmaceutical Co., Ltd.
Troxerutin for injection
Indication: It is used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), thrombophlebitis, central retinitis, edema caused by increased vascular permeability, etc.
Manufacturer:
Yantai Dongcheng Beifang Pharmaceutical Co., Ltd.
Troxerutin for injection
Indication: It is used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), thrombophlebitis, central retinitis, edema caused by increased vascular permeability, etc.
Manufacturer:
Hunan Wzt Pharmaceutical Co., Ltd.
Related Ingredients